Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedDec 3, 2014Leuprolide 50 mcg/0.1 mL Micro Lupron KitLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0262-2015Class IITerminatedDec 3, 2014Tri-MixLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0261-2015Class IITerminatedDec 3, 2014Methyl B12 25 mg/mL InjLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0260-2015Class IITerminatedDec 3, 2014Testosterone CYP-250/PROP-20 mgLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0259-2015Class IITerminatedDec 3, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Presence of split or broken tablets.Actavis Laboratories, FL, Inc. · D-0258-2015Class IIITerminatedDec 3, 2014Amlodipine Besylate TabletsDiscoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.Zydus Pharmaceuticals USA Inc · D-0257-2015Class IITerminatedDec 3, 2014Potassium Chloride InjectionLabeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride Injection...Baxter Healthcare Corp. · D-0256-2015Class IITerminatedNov 26, 2014Tetrahydrozoline HydrochlorideCGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.Spectrum Laboratory Products · D-0255-2015Class IIITerminatedNov 26, 2014Sterile powder Vancomycin Hydrochloride for InjectionCorrect Labeled Product Mispack: Product tray containing vials was mislabeled to contain another product.Hospira Inc. · D-0254-2015Class IITerminatedNov 26, 2014LOSARTAN POTASSIUM TABLETS USPFailed Content Uniformity Specifications; Dry mix failed blend uniformity.Micro Labs Usa, Inc S · D-0253-2015Class ITerminatedNov 26, 2014Trace Mineral-5 MDVNon-Sterility; contract laboratory identified Staphylococcus warneri in the productAbrams Royal Pharmacy · D-0252-2015Class ITerminatedNov 26, 2014Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mLNon-SterilityAbrams Royal Pharmacy · D-0251-2015Class ITerminatedNov 26, 2014Calcium Chloride Preservative Free Sterile injectionNon-Sterility: The firm's contract testing laboratory found sterility failures.Abrams Royal Pharmacy · D-0250-2015Class IITerminatedNov 26, 2014Mercaptopurine TabletsFailed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.Prometheus Laboratories Inc. · D-0249-2015Class IITerminatedNov 19, 2014Assured Naproxen Sodium TabletsCorrect Labeled Product Mispacked; correct labeled bottles of Assured Ibuprofen softgels were packaged into cartons of Assured Naproxen Sodium Tablets, USPContract Packaging Resources Inc. · D-0248-2015Class IIITerminatedNov 19, 2014HALOPERIDOL DECANOATE INJECTIONFailed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.Fresenius Kabi USA LLC · D-0247-2015Class IIITerminatedNov 19, 2014Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed Impurity content (Butylated Hydroxy Anisole Content) against shelf life specification.Micro Labs Usa, Inc S · D-0246-2015Class IITerminatedNov 19, 2014FLUOCINONIDE GEL USPFailed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.Fougera Pharmaceuticals Inc. · D-0245-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0244-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0243-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0242-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0241-2015Class IITerminatedNov 12, 2014Cyproheptadine HCl SyrupFailed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.Pharmaceutical Associates Inc · D-0240-2015Class IIITerminatedNov 12, 2014Loratadine 24 HR-OTCFailed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.Physicians Total Care, Inc. · D-0239-2015Class IIITerminatedNov 12, 2014Z-COTE HP 1 TRANSPARENT ZINC OXIDEcGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.Nanophase Technologies Corporation · D-0238-2015Class IITerminatedNov 12, 2014CEPHALEXIN MONOHYDRATE CAPSULESCGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.Physicians Total Care, Inc. · D-0237-2015Class IITerminatedNov 12, 2014Venlafaxine Hydrochloride Extended-Release TabletsFailed Dissolution Specifications; 12 month stability time pointSun Pharma Global Inc. · D-0236-2015Class IIITerminatedNov 12, 2014TORISEL KitCrystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL...Pfizer Inc. · D-0235-2015Class IITerminatedNov 12, 2014Obagi Nu-Derm ClearLabeling: Label Mix-Up; Containers of the Obagi Nu-Derm Clear pre-labeled bottles were inadvertently introduced into the Obagi Exfoderm Forte packaging line. Therefore...Obagi Medical Products · D-0234-2015Class IITerminatedNov 12, 2014VITAMIN B COMPLEXLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0228-2015Class IITerminatedNov 12, 2014VANCOMYCINLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0227-2015Class IITerminatedNov 12, 2014TRIESENCELack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0226-2015Class IITerminatedNov 12, 2014TOBRAMYCINLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0225-2015Class IITerminatedNov 12, 2014TESTOSTERONE CYPIONATELack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0224-2015Class IITerminatedNov 12, 2014TESTOSTERONE CYPIONATELack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0223-2015Class IITerminatedNov 12, 2014SODIUM CHLORIDE INHALATIONLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0222-2015Class IITerminatedNov 12, 2014PYRIDOXINE HCLLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0221-2015Class IITerminatedNov 12, 2014PROCAINE HCLLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0220-2015Class IITerminatedNov 12, 2014PREDNISOLONE Sodium PhosphateLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0219-2015Class IITerminatedNov 12, 2014PAPAVERINE/PHENTOLAMINE/PROSTAGLANDINLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0218-2015

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.